RayCare 2024A interoperable with Varian TrueBeam
In
TrueBeam is Varian's most prevalent treatment delivery platform and has been installed in thousands of radiation therapy clinics in the world since its launch in 2010. It supports all treatment techniques and capabilities that are provided by so called c-arm linacs, including IMRT, VMAT and electrons with flexible beam energy selection and non-coplanar beam arrangements. The interoperability certificate applies to linacs in the TrueBeam family equipped with kV imaging: TrueBeam, TrueBeam STx, Edge and VitalBeam.
Johan Löf, founder and CEO, RaySearch, says: "Interoperability with treatment delivery systems is a key feature of RayCare and it is gratifying to see that the interoperability of the latest version of RayCare with TrueBeam has been achieved in time for the release and I look forward to clinical implementation of the connection later in 2024."
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
* Subject to regulatory clearance in some markets.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
RaySearch Press Release |
View original content:https://www.prnewswire.com/news-releases/raycare-2024a-interoperable-with-varian-truebeam-302147626.html
SOURCE RaySearch Laboratories
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coppin State University Lowers Costs for Residential Students Amid Rising Higher Education Expenses
- The Coolest Meet-Cute Yet: 7-Eleven, Inc. Celebrates 60 Years of Slurpee® by Setting Out to Spark More Anniversaries with the First-Ever Slurpee Date
- REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share